BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30185813)

  • 41. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
    Bayraktar R; Pichler M; Kanlikilicer P; Ivan C; Bayraktar E; Kahraman N; Aslan B; Oguztuzun S; Ulasli M; Arslan A; Calin G; Lopez-Berestein G; Ozpolat B
    Oncotarget; 2017 Feb; 8(7):11641-11658. PubMed ID: 28036267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.
    Powell CA; Nasser MW; Zhao H; Wochna JC; Zhang X; Shapiro C; Shilo K; Ganju RK
    Oncotarget; 2015 Mar; 6(8):6373-85. PubMed ID: 25779666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer.
    Wu X; Zahari MS; Renuse S; Kelkar DS; Barbhuiya MA; Rojas PL; Stearns V; Gabrielson E; Malla P; Sukumar S; Mahajan NP; Pandey A
    Oncotarget; 2017 Jan; 8(2):2971-2983. PubMed ID: 27902967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.
    Park S; Sung Y; Jeong J; Choi M; Lee J; Kwon W; Jang S; Park SJ; Kim HS; Lee MH; Kim DJ; Liu K; Kim SH; Dong Z; Ryoo ZY; Kim MO
    Oncotarget; 2017 Jun; 8(23):37115-37127. PubMed ID: 28415749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine.
    Hu J; Zhang Y; Jiang X; Zhang H; Gao Z; Li Y; Fu R; Li L; Li J; Cui H; Gao N
    J Exp Clin Cancer Res; 2019 May; 38(1):225. PubMed ID: 31138329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer.
    Wu YH; Hong CW; Wang YC; Huang WJ; Yeh YL; Wang BJ; Wang YJ; Chiu HW
    Cancer Lett; 2017 Aug; 400():79-88. PubMed ID: 28450160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Compromised JMJD6 Histone Demethylase Activity Affects VHL Gene Repression in Preeclampsia.
    Alahari S; Post M; Rolfo A; Weksberg R; Caniggia I
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1545-1557. PubMed ID: 29373688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer.
    Cioni B; Ratti S; Piva A; Tripodi I; Milani M; Menichetti F; Langella T; Botti L; De Cecco L; Chiodoni C; Lecis D; Colombo MP
    Mol Cancer Res; 2023 Jun; 21(6):614-627. PubMed ID: 36867680
    [TBL] [Abstract][Full Text] [Related]  

  • 49. JMJD6 Regulates Splicing of Its Own Gene Resulting in Alternatively Spliced Isoforms with Different Nuclear Targets.
    Raguz N; Heim A; Engal E; Wesche J; Merl-Pham J; Hauck SM; Erkelenz S; Schaal H; Bensaude O; Wolf A; Salton M; Böttger A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells.
    Wu W; Ma J; Shao N; Shi Y; Liu R; Li W; Lin Y; Wang S
    PLoS One; 2017; 12(1):e0169229. PubMed ID: 28046018
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
    Wang S; Liang Y; Chang W; Hu B; Zhang Y
    Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer.
    Ye L; Li F; Song Y; Yu D; Xiong Z; Li Y; Shi T; Yuan Z; Lin C; Wu X; Ren L; Li X; Song L
    Int J Cancer; 2018 Nov; 143(10):2602-2613. PubMed ID: 30151890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The oxygenase Jmjd6--a case study in conflicting assignments.
    Böttger A; Islam MS; Chowdhury R; Schofield CJ; Wolf A
    Biochem J; 2015 Jun; 468(2):191-202. PubMed ID: 25997831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural Mechanism of the Oxygenase JMJD6 Recognition by the Extraterminal (ET) Domain of BRD4.
    Konuma T; Yu D; Zhao C; Ju Y; Sharma R; Ren C; Zhang Q; Zhou MM; Zeng L
    Sci Rep; 2017 Nov; 7(1):16272. PubMed ID: 29176719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Redistribution of demethylated RNA helicase A during foot-and-mouth disease virus infection: role of Jumonji C-domain containing protein 6 in RHA demethylation.
    Lawrence P; Conderino JS; Rieder E
    Virology; 2014 Mar; 452-453():1-11. PubMed ID: 24606677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231.
    Yang M; Li Y; Ruan Y; Lu Y; Lin D; Xie Y; Dong B; Dang Q; Quan C
    Mol Cell Biochem; 2018 Jun; 443(1-2):169-180. PubMed ID: 29159771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. JMJD6 regulates ERα methylation on arginine.
    Poulard C; Rambaud J; Hussein N; Corbo L; Le Romancer M
    PLoS One; 2014; 9(2):e87982. PubMed ID: 24498420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FSIP1 regulates autophagy in breast cancer.
    Liu C; Sun L; Yang J; Liu T; Yang Y; Kim SM; Ou X; Wang Y; Sun L; Zaidi M; New MI; Yuen T; Guo Q
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):13075-13080. PubMed ID: 30509973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors.
    Su Y; Hopfinger NR; Nguyen TD; Pogash TJ; Santucci-Pereira J; Russo J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):314. PubMed ID: 30547810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.